Middle cerebral artery

RapidAI Receives First and Only FDA 510(k) Clearance of Non-Contrast CT Imaging Product to Accelerate Acute Stroke Triage

Retrieved on: 
星期二, 四月 18, 2023
Technology, Medical Devices, FDA, Health Technology, Software, Hardware, Radiology, Health, Artificial Intelligence, CT, Stroke, Intelligence, CTA, ICH, Rapids, Hospital, Triage, Intracranial hemorrhage, Patient, NCCT, Middle cerebral artery, ICA, Trauma, PACS, LVO, Medical imaging

Rapid NCCT Stroke uses artificial intelligence to analyze non-contrast CT (NCCT) images to determine suspicion of ICH and LVO of the distal internal carotid artery (ICA) and middle cerebral artery (MCA-M1).

Key Points: 
  • Rapid NCCT Stroke uses artificial intelligence to analyze non-contrast CT (NCCT) images to determine suspicion of ICH and LVO of the distal internal carotid artery (ICA) and middle cerebral artery (MCA-M1).
  • The fully automated system then delivers triage and prioritization notifications through PACS, email, and the Rapid mobile app.
  • For hospitals that do advanced imaging, Rapid NCCT Stroke may significantly reduce the time between CT and CTA scans.
  • “Our hope is that by providing better information early for more informed treatment and transfer decisions, Rapid NCCT Stroke will support faster stroke care and better patient outcomes.

Aidoc Secures New FDA Clearances Enabling Faster and More Accurate Detection of Critical Neurological and Cardiovascular Conditions

Retrieved on: 
星期四, 十一月 17, 2022
Triage, AD, LVO, Thoracic aortic aneurysm, EHR, Surgery, Stroke, Length of stay, Mevo, Radiology, Physician, M1, FDA, Doctor Foster, Aidoc, ICA, Computer-aided simple triage, Intelligence, Abdominal aortic aneurysm, Middle cerebral artery, Anterior cerebral artery, Patient, PCA, COVID-19, Pressure, Surgeon, Communication, Basilar artery, Posterior cerebral artery, Brain, Vos, MCA, AI, Vertebral artery, ACA, Ambient occlusion, Yale New Haven Hospital, CT, Medical device, Medicine, Medical imaging, Mevo Modi'im

NEW YORK, Nov. 17, 2022 /PRNewswire/ -- Aidoc, the leading provider of healthcare AI solutions, today announced it has increased its FDA clearances to 11 with the addition of CT-based AI solutions - aortic dissection (AD) and all vessel occlusions (VOs). These clearances continue Aidoc's impressive momentum and leadership in healthcare AI, giving the organization the most FDA clearances in the AI imaging space.

Key Points: 
  • These clearances continue Aidoc's impressive momentum and leadership in healthcare AI, giving the organization the most FDA clearances in the AI imaging space.
  • "Effective healthcare and treatment of acute conditions, like stroke and aortic dissections, require rapid, coordinated care minutes can matter," said Aidoc CEO Elad Walach.
  • Aidoc is the only company with a proven EHR integration for the population of critical, time-sensitive patient information on the app.
  • Aidoc is the leading provider of artificial intelligence healthcare solutions that empower physicians to expedite patient treatment and enhance quality of care.

Imperative Care Announces Positive New Data Underscoring the Safety and Efficacy of the Zoom Stroke Solution to Treat Distal Occlusions in Ischemic Stroke Patients

Retrieved on: 
星期三, 八月 24, 2022
General Health, Neurology, Medical Devices, Other Health, Health, COO, Moyamoya disease, Technology, National Institute, Safety, Zoom, MCA, Brain, Intracranial hemorrhage, Solution, National Institutes of Health Stroke Scale, Contraindication, Physician, STAR, IQR, Veni, vidi, vici, Intervention, Annual general meeting, AJNR, Middle cerebral artery, Stroke, Reperfusion, World government, Risk, Patient, Anatomical terms of location, Medical device, Dentistry, Pharmaceutical industry, SWIFT

today announced that new data evaluating the utility of the Zoom Stroke Solution were presented at the World Federation of Interventional and Therapeutic Neuroradiology (WFITN) 2022 Annual Meeting in Kyoto.

Key Points: 
  • today announced that new data evaluating the utility of the Zoom Stroke Solution were presented at the World Federation of Interventional and Therapeutic Neuroradiology (WFITN) 2022 Annual Meeting in Kyoto.
  • The Zoom Stroke Solution is the complete stroke system from access through reperfusion for fast and effective clot removal for patients with acute ischemic stroke.
  • The system includes the Zoom 88 Large Distal Platform for neurovascular access, four vessel-matched Zoom Aspiration Catheters, the Zoom Pump, the Zoom POD and other accessories.
  • Imperative Care and Truvic are based in Campbell, Calif. https://imperativecare.com
    + Dr. Torok is a paid consultant for Imperative Care.